Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors

NAActive, not recruitingINTERVENTIONAL
Enrollment

5,196

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

January 26, 2025

Study Completion Date

January 31, 2026

Conditions
Papillomavirus Vaccines
Interventions
BEHAVIORAL

HPV-PROTECT

HPV-PROTECT is a multicomponent provider-focused intervention specifically tailored for use in pediatric oncology settings, addressing important survivor-specific vaccine issues. The intervention is comprised of three components, i) Provider Communication Training; ii) Assessment and Peer Feedback/ Coaching; and iii) Provider Toolkit. The HPV-PROTECT intervention is designed to increase provider knowledge regarding use of the HPV vaccine in the cancer survivor population, enhance provider skills in delivering brief, compelling HPV vaccine recommendations to parents of young cancer survivors, present ongoing feedback to providers regarding clinic- and provider-level survivor HPV vaccination rates, and decrease barriers to receipt of vaccine by survivors through the provision of Vaccine Action Plans, tailored to local context.

Trial Locations (6)

30322

Emory University, Atlanta

35233

University of Alabama at Birmingham, Birmingham

55455-0341

University of Minnesota, Minneapolis

27157-0001

Wake Forest University Health Sciences, Winston-Salem

97239-3098

Oregon Health and Science University, Portland

77030-3411

Baylor College of Medicine, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Alabama at Birmingham

OTHER